Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma

医学 化疗 放射治疗 肿瘤科 氟尿嘧啶 临床终点 内科学 鼻咽癌 外科 危险系数 随机对照试验 置信区间
作者
Rui You,You‐Ping Liu,Pei‐Yu Huang,Xiong Zou,Rui Sun,Yuxiang He,Yi‐Shan Wu,Guo‐Ping Shen,Hongdan Zhang,Chongyang Duan,Sze Huey Tan,Jingyu Cao,Jibin Li,Yu‐Long Xie,Yi‐Nuan Zhang,Zhi‐Qiang Wang,Qi Yang,Mei Lin,Rou Jiang,Mengxia Zhang
出处
期刊:JAMA Oncology [American Medical Association]
卷期号:6 (9): 1345-1345 被引量:248
标识
DOI:10.1001/jamaoncol.2020.1808
摘要

Importance: The role of locoregional radiotherapy in patients with de novo metastatic nasopharyngeal carcinoma (mNPC) is unclear. Objective: To investigate the efficacy and safety of locoregional radiotherapy in de novo mNPC. Design, Setting, and Participants: Patients with biopsy-proven mNPC, who demonstrated complete or partial response (RECIST v1.1) following 3 cycles of cisplatin and fluorouracil chemotherapy, were enrolled. Eligible patients were randomly assigned (1:1) to receive either chemotherapy plus radiotherapy or chemotherapy alone. Overall, 126 of 173 patients screened were eligible to the study, and randomized to chemotherapy plus radiotherapy (n = 63) or chemotherapy alone (n = 63). Median (IQR) follow-up duration was 26.7 (17.2-33.5) months. Interventions: The chemotherapy regimens were fluorouracil continuous intravenous infusion at 5 g/m2 over 120 hours and 100 mg/m2 intravenous cisplatin on day 1, administered every 3 weeks for 6 cycles. Patients assigned to the chemotherapy plus radiotherapy group received intensity-modulated radiotherapy (IMRT) after chemotherapy. Main Outcomes and Measures: The primary end point of the study was overall survival (OS). The secondary end point was progression-free survival (PFS) and safety. Results: Overall, 126 patients were enrolled (105 men [83.3%] and 21 women [16.7%]; median [IQR] age, 46 [39-52] years). The 24-month OS was 76.4% (95% CI, 64.4%-88.4%) in the chemotherapy plus radiotherapy group, compared with 54.5% (95% CI, 41.0%-68.0%) in the chemotherapy-alone group. The study met its primary end point of improved OS (stratified hazard ratio [HR], 0.42; 95% CI, 0.23-0.77; P = .004) in favor of chemotherapy plus radiotherapy. Progression-free survival was also improved in the chemotherapy plus radiotherapy group compared with the chemotherapy-alone group (stratified HR, 0.36; 95% CI, 0.23-0.57). No significant differences in acute hematological or gastrointestinal toxic effects were observed between the treatment arms. The frequency of acute grade 3 or higher dermatitis, mucositis, and xerostomia was 8.1%, 33.9%, and 6.5%, respectively, in the chemotherapy plus radiotherapy group. The frequency of late severe grade 3 or higher hearing loss and trismus was 5.2% and 3.4%, respectively, in the chemotherapy plus radiotherapy group. Conclusions and Relevance: In this randomized clinical trial, radiotherapy added to chemotherapy significantly improved OS in chemotherapy-sensitive patients with mNPC. Trial Registration: ClinicalTrials.gov Identifier: NCT02111460.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zxh完成签到,获得积分10
刚刚
1秒前
2秒前
2秒前
于66发布了新的文献求助10
3秒前
科研通AI2S的应助被时尚篮球采纳,获得10
4秒前
所所的应助被winnerbing采纳,获得10
4秒前
英姑的应助被时尚篮球采纳,获得10
4秒前
充电宝的应助被时尚篮球采纳,获得10
4秒前
chenjunhuan发布了新的文献求助10
5秒前
6秒前
molihuakai的应助被谨慎的秋烟采纳,获得10
7秒前
盈虚者发布了新的文献求助10
8秒前
theverve发布了新的文献求助10
8秒前
9秒前
小蘑菇的应助被铁头霸霸采纳,获得10
10秒前
zhangzhangZZZ完成签到,获得积分10
10秒前
11秒前
科目三的应助被ZRJ采纳,获得10
11秒前
Cc完成签到 ,获得积分10
12秒前
orixero的应助被眼睛大的书易采纳,获得10
12秒前
12秒前
泪西瓜完成签到,获得积分10
13秒前
Ava的应助被缪甲烷采纳,获得10
13秒前
丫丫完成签到 ,获得积分10
13秒前
14秒前
温温完成签到 ,获得积分10
14秒前
14秒前
15秒前
wuwui完成签到 ,获得积分10
16秒前
林阙发布了新的文献求助10
18秒前
18秒前
Zz发布了新的文献求助10
18秒前
上官若男的应助被苹果思天采纳,获得10
18秒前
Ethereal发布了新的文献求助10
18秒前
19秒前
20秒前
21秒前
21秒前
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158056
求助须知:如何正确求助?哪些是违规求助? 9553944
关于积分的说明 21716733
捐赠科研通 7747388
什么是DOI,文献DOI怎么找? 3426934
关于科研通互助平台的介绍 2551676
邀请新用户注册赠送积分活动 2471038